S3844 Insurance Policy Changes

HCPCS S3844 is officially defined as "Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness." HCPCS S3844 is referenced in 1 tracked payer policy change from BlueCross BlueShield of South Carolina. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S3844 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Related

All billing codesJ35909921399212992029921499203

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert